FLNA (Filana Therapeutics, Inc. Common Stock) Stock Analysis - SEC Filings

Filana Therapeutics, Inc. Common Stock (FLNA) is a publicly traded the market company. As of May 21, 2026, FLNA trades at $1.23 with a market cap of $57.49M and a P/E ratio of 0.00. FLNA moved +4.58% today. Year to date, FLNA is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $1.16 to $2.27. Rallies surfaces FLNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find FLNA SEC filings?

Rallies organizes FLNA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

FLNA Key Metrics

Key financial metrics for FLNA
MetricValue
Price$1.23
Market Cap$57.49M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$2.27
52-Week Low$1.16
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest FLNA News

FLNA Analyst Consensus

FLNA analyst coverage data. Average price target: $0.00.

Common questions about FLNA

Where can I find FLNA SEC filings?
Rallies organizes FLNA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show FLNA 10-K and 10-Q filings?
Rallies organizes FLNA SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is FLNA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for FLNA. It does not provide personalized investment advice.
FLNA

FLNA